Cargando…

Brain- and brain tumor-penetrating disulfiram nanoparticles: Sequence of cytotoxic events and efficacy in human glioma cell lines and intracranial xenografts

There is great interest in repurposing disulfiram (DSF), a rapidly metabolizing nontoxic drug, for brain cancers and other cancers. To overcome the instability and low therapeutic efficacy, we engineered passively-targeted DSF-nanoparticles (DSFNPs) using biodegradable monomethoxy (polyethylene glyc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Madala, Hanumantha Rao, Punganuru, Surendra R., Ali-Osman, Francis, Zhang, Ruiwen, Srivenugopal, Kalkunte S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790476/ https://www.ncbi.nlm.nih.gov/pubmed/29423059 http://dx.doi.org/10.18632/oncotarget.23320

Ejemplares similares

S-phase Specific Downregulation of Human O(6)-Methylguanine DNA Methyltransferase (MGMT) and its Serendipitous Interactions with PCNA and p21(cip1) Proteins in Glioma Cells
por: Mostofa, AGM, et al.
Publicado: (2018)

Characterization of a highly specific NQO1-activated near-infrared fluorescent probe and its application for in vivo tumor imaging
por: Punganuru, Surendra Reddy, et al.
Publicado: (2019)

The Process and Regulatory Components of Inflammation in Brain Oncogenesis
por: Mostofa, A.G.M., et al.
Publicado: (2017)

Cancer-Specific Biomarker hNQO1-Activatable Fluorescent Probe for Imaging Cancer Cells In Vitro and In Vivo
por: Punganuru, Surendra Reddy, et al.
Publicado: (2018)

Beyond Brooding on Oncometabolic Havoc in IDH-Mutant Gliomas and AML: Current and Future Therapeutic Strategies
por: Madala, Hanumantha Rao, et al.
Publicado: (2018)

Conception, synthesis, and characterization of a rofecoxib-combretastatin hybrid drug with potent cyclooxygenase-2 (COX-2) inhibiting and microtubule disrupting activities in colon cancer cell culture and xenograft models
por: Punganuru, Surendra R., et al.
Publicado: (2018)

New insights into estrogenic regulation of O(6)-methylguanine DNA-methyltransferase (MGMT) in human breast cancer cells: Co-degradation of ER-α and MGMT proteins by fulvestrant or O(6)-benzylguanine indicates fresh avenues for therapy
por: Paranjpe, Ameya, et al.
Publicado: (2016)

Targeted Brain Tumor Therapy by Inhibiting the MDM2 Oncogene: In Vitro and In Vivo Antitumor Activity and Mechanism of Action
por: Punganuru, Surendra R., et al.
Publicado: (2020)

Genomic Space of MGMT in Human Glioma Revisited: Novel Motifs, Regulatory RNAs, NRF1, 2, and CTCF Involvement in Gene Expression
por: Ibrahim Al-Obaide, Mohammed A., et al.
Publicado: (2021)

The MDM2-p53 pathway revisited
por: Nag, Subhasree, et al.
Publicado: (2013)

Transcriptional Pausing and Activation at Exons-1 and -2, Respectively, Mediate the MGMT Gene Expression in Human Glioblastoma Cells
por: Al-Obaide, Mohammed A. Ibrahim, et al.
Publicado: (2021)

Disulfiram in glioma: Literature review of drug repurposing
por: Zhong, Shiyu, et al.
Publicado: (2022)

The cytotoxic mechanisms of disulfiram and copper(ii) in cancer cells
por: Tawari, Patricia Erebi, et al.
Publicado: (2015)

Differential Cytotoxicity Mechanisms of Copper Complexed with Disulfiram in Oral Cancer Cells
por: Chen, Ssu-Yu, et al.
Publicado: (2021)

Eribulin penetrates brain tumor tissue and prolongs survival of mice harboring intracerebral glioblastoma xenografts
por: Takahashi, Masamichi, et al.
Publicado: (2019)

Alcohol-abuse drug disulfiram targets pediatric glioma via MLL degradation
por: Meier, Stefanie, et al.
Publicado: (2021)

Disulfiram-induced cytotoxicity and endo-lysosomal sequestration of zinc in breast cancer cells
por: Wiggins, Helen L., et al.
Publicado: (2015)

A brain-penetrant microtubule-targeting agent that disrupts hallmarks of glioma tumorigenesis
por: Horne, Eric A, et al.
Publicado: (2020)

Intracranial glioma xenograft model rapidly reestablishes blood–brain barrier integrity for longitudinal imaging of tumor progression using fluorescence molecular tomography and contrast agents
por: Habimana-Griffin, LeMoyne, et al.
Publicado: (2020)

Mesenchymal stromal cells loaded with paclitaxel induce cytotoxic damage in glioblastoma brain xenografts
por: Pacioni, Simone, et al.
Publicado: (2015)

Disulfiram Induced Psychosis
por: Mohapatra, Satyakam, et al.
Publicado: (2017)

Disulfiram Treatment of Alcoholism
por: Anton, Raymond F.
Publicado: (1995)

Encephalopathy caused by disulfiram
por: Sant’Angelo, R., et al.
Publicado: (2021)

Recent Advances in Repurposing Disulfiram and Disulfiram Derivatives as Copper-Dependent Anticancer Agents
por: Kannappan, Vinodh, et al.
Publicado: (2021)

A Comparative Cytotoxic Evaluation of Disulfiram Encapsulated PLGA Nanoparticles on MCF-7 Cells
por: Fasehee, Hamidreza, et al.
Publicado: (2017)

Identify a Blood-Brain Barrier Penetrating Drug-TNB using Zebrafish Orthotopic Glioblastoma Xenograft Model
por: Zeng, Anqi, et al.
Publicado: (2017)

Comparative Effectiveness of Intracranial Pressure Monitoring vs No Monitoring in Severe Penetrating Brain Injury Management
por: Mansour, Ali, et al.
Publicado: (2023)

Brain-Penetrating Nanoparticles Improve Paclitaxel Efficacy in Malignant Glioma Following Local Administration
por: Nance, Elizabeth, et al.
Publicado: (2014)

An Asp to Strike Out Cancer? Therapeutic Possibilities Arising from Aspartate’s Emerging Roles in Cell Proliferation and Survival
por: Helenius, Iiro Taneli, et al.
Publicado: (2021)

Repurposing Disulfiram as an Antifungal Agent: Development of a New Disulfiram Vaginal Mucoadhesive Gel
por: Lajarin-Reinares, Maria, et al.
Publicado: (2023)

Sexual dysfunction in alcohol-dependent men on disulfiram or baclofen prophylaxis: A preliminary report
por: Grover, Sandeep, et al.
Publicado: (2014)

Establishing Intracranial Brain Tumor Xenografts With Subsequent Analysis of Tumor Growth and Response to Therapy using Bioluminescence Imaging
por: Ozawa, Tomoko, et al.
Publicado: (2010)

Disulfiram—Mitigating Unintended Effects
por: Grout, Martha M., et al.
Publicado: (2023)

Disulfiram: Mechanisms, Applications, and Challenges
por: Lanz, Jenna, et al.
Publicado: (2023)

Characterization of the Blood–Brain Barrier Integrity and the Brain Transport of SN-38 in an Orthotopic Xenograft Rat Model of Diffuse Intrinsic Pontine Glioma
por: Chaves, Catarina, et al.
Publicado: (2020)

Disulfiram Acts as a Potent Radio-Chemo Sensitizer in Head and Neck Squamous Cell Carcinoma Cell Lines and Transplanted Xenografts
por: Yao, Wenhao, et al.
Publicado: (2021)

Temozolomide and Reirradiation in Recurrent Grade II Brain Glioma
por: Osman, Mohammed A
Publicado: (2014)

Management of penetrating brain injury
por: Kazim, Syed Faraz, et al.
Publicado: (2011)

Penetrating brain injury with hypopituitarism
por: Appelbaum, Rachel D., et al.
Publicado: (2022)

Dendritic cells resist to disulfiram-induced cytotoxicity, but reduced interleukin-12/23(p40) production
por: Jung, Haebeen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_n75h5o4n14vt7memq5hd4m33bk